News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XClinical GmbH's Dr. Philippe Verplancke Member of CDISC E3C


4/24/2009 11:38:56 AM

MUNICH--(BUSINESS WIRE)--XClinical, a European vendor of innovative software products for eClinical trials, today announced the election of its CEO Dr. Philippe Verplancke as a member of the European CDISC Coordinating Committee (E3C). After a series of interviews with representatives of the industry, the current E3C members decided to appoint Dr. Philippe Verplancke. “I’m very happy to help promote the adoption of CDISC standards throughout Europe”, Dr. Verplancke pointed out.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES